FM

Frazier Management Portfolio holdings

AUM $1.12M
This Quarter Return
+4.88%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
AUM
$1.25B
AUM Growth
+$1.25B
Cap. Flow
+$181M
Cap. Flow %
14.47%
Top 10 Hldgs %
67.15%
Holding
42
New
8
Increased
10
Reduced
5
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARQT icon
1
Arcutis Biotherapeutics
ARQT
$1.86B
$201M 16.12% 8,434,232
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$864M
$187M 14.97% 5,827,415
MIRM icon
3
Mirum Pharmaceuticals
MIRM
$3.71B
$71.1M 5.69% 3,566,912
IOVA icon
4
Iovance Biotherapeutics
IOVA
$807M
$65.9M 5.28% 2,674,299 +536,300 +25% +$13.2M
IMGO
5
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$59.5M 4.76% +2,971,274 New +$59.5M
PCVX icon
6
Vaxcyte
PCVX
$4B
$58.6M 4.69% 2,309,554
TRIL
7
DELISTED
Trillium Therapeutics Inc.
TRIL
$55M 4.4% 3,123,107
GRTS
8
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$50.4M 4.03% 4,667,242 +3,636,364 +353% +$39.3M
PASG icon
9
Passage Bio
PASG
$22.7M
$49.9M 3.99% 5,009,219
KRYS icon
10
Krystal Biotech
KRYS
$4.27B
$40.3M 3.22% 771,250 -16,626 -2% -$868K
TARS icon
11
Tarsus Pharmaceuticals
TARS
$2.47B
$30.5M 2.44% 1,417,157
ISEE
12
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$29.9M 2.39% 1,838,402 -706,098 -28% -$11.5M
STRO icon
13
Sutro Biopharma
STRO
$72.7M
$27.7M 2.22% 1,468,663 +467,242 +47% +$8.83M
VRDN icon
14
Viridian Therapeutics
VRDN
$1.5B
$24.8M 1.98% +1,505,200 New +$24.8M
ANAB icon
15
AnaptysBio
ANAB
$569M
$24.4M 1.95% 899,700
AUTL
16
Autolus Therapeutics
AUTL
$399M
$23.1M 1.85% 3,530,657 +1,246,691 +55% +$8.17M
SNDX icon
17
Syndax Pharmaceuticals
SNDX
$1.41B
$22.7M 1.82% 1,188,135
TYRA icon
18
Tyra Biosciences
TYRA
$675M
$22M 1.76% +1,250,000 New +$22M
KDNY
19
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$21.3M 1.71% 1,671,918 +571,918 +52% +$7.3M
ALPN
20
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$18.9M 1.51% 1,771,844 -799,606 -31% -$8.53M
BCYC
21
Bicycle Therapeutics
BCYC
$511M
$18.4M 1.47% +442,880 New +$18.4M
CRNX icon
22
Crinetics Pharmaceuticals
CRNX
$2.92B
$17.9M 1.43% +851,306 New +$17.9M
SRRA
23
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$17.6M 1.41% 804,667 +601,864 +297% +$13.2M
FLACU
24
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$15.1M 1.2% 1,501,000
REPL icon
25
Replimune Group
REPL
$422M
$14.6M 1.17% +491,998 New +$14.6M